NS Wind Down Co

NS Wind Down Co Equity

Delisted

The The Equity of NS Wind Down Co (NSTGQ) as of Oct 30, 2026 is 45.81 M USD. In the previous year, The Equity was 176.96 M USD — a change of -74.11% (lower).

Equity

45.81 MUSD

YoY

-74.11%

Last updated:

In 2022, NS Wind Down Co's equity was 45.81 M USD, a -74.11% increase from the 176.96 M USD equity in the previous year.

The NS Wind Down Co Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2015
20.20 M USD
Jan 1, 2016
12.30 M USD
Jan 1, 2017
40.10 M USD
Jan 1, 2018
36.90 M USD
Jan 1, 2019
104.15 M USD
Jan 1, 2020
306.95 M USD
Jan 1, 2021
176.96 M USD
Jan 1, 2022
45.81 M USD
The NS Wind Down Co Equity history
YEAREquityYoY
45.81 MUSD-74.11%
176.96 MUSD-42.35%
306.95 MUSD+194.71%
104.15 MUSD+182.25%
36.90 MUSD-7.98%
40.10 MUSD+226.02%
12.30 MUSD-39.11%
20.20 MUSD-54.91%
44.80 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NS Wind Down Co Stock analysis

What does NS Wind Down Co do? NanoString Technologies Inc. is a company based in Seattle, USA, founded in 2003. The company's main focus is the development and commercialization of diagnostic tests and platforms for genomics and proteomics. Business Model: NanoString Technologies offers innovative solutions for gene and protein analysis. The company's products are used worldwide by researchers, clinics, and pharmaceutical companies to better understand diseases, make more precise diagnoses, and develop therapies. The company targets both academic research and industry. Divisions and Products: In the genomics field, NanoString Technologies offers the nCounter® platform. This technology allows for the measurement of the expression of over 800 genes simultaneously directly in tissue samples. mRNA is converted to cDNA and then detected using barcodes. The method is highly specific and sensitive, which is particularly advantageous in cancer research. For protein analysis, NanoString Technologies offers the GeoMx® Digital Spatial Profiling (DSP) platform. This allows for the direct localization and quantification of proteins in tissue sections. The method is high-resolution and enables the investigation of protein expressions within a cell community. In addition to these platforms, the company also offers various panels that can measure a specific amount of genes or proteins at once. These include, for example, the PanCancer Immune Profiling Panel, which provides information about the immune response in tumors, or the nCounter® Neuropathology Panel, which is used for the diagnosis of neurological disorders. History: NanoString Technologies was founded in 2003 by brothers Krassen and Dimitris Draganov. They developed the nCounter® platform, which was officially launched in 2008. In 2010, the company received a $20 million investment, which allowed for the expansion of the product range. Further funding rounds followed and the successful IPO took place in June 2013. Since then, the company has focused on expanding its product portfolio and improving its technologies. Conclusion: NanoString Technologies has quickly established itself as a major provider in the genomics and proteomics field. The nCounter® and GeoMx® platforms have proven to be highly specific and sensitive analysis tools and are used worldwide in research and diagnostics. NanoString Technologies is an innovative company with promising products and is likely to continue playing an important role in the biotechnology industry in the future. NS Wind Down Co is one of the most popular companies on Eulerpool.

Equity Details

Analyzing NS Wind Down Co's Equity

NS Wind Down Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding NS Wind Down Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating NS Wind Down Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

NS Wind Down Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in NS Wind Down Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about NS Wind Down Co stock

The Equity of NS Wind Down Co is 45.81 M USD in 2022.

The Equity of NS Wind Down Co changed from 176.96 M USD to 45.81 M USD, representing a -74.11% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity NS Wind Down Co since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's NS Wind Down Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — NS Wind Down Co

All Key Metrics — NS Wind Down Co